Stockreport

Opus Genetics to Participate in Leading Medical Conferences in May 2026

Opus Genetics, Inc.  (IRD) 
PDF RESEARCH TRIANGLE PARK, N.C., April 27, 2026 (GLOBE NEWSWIRE) -- Opus Genetics (Nasdaq: IRD) (“Opus Genetics” or the “Company”), a clinical-stage biopharmaceutical com [Read more]